Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma

NCT00450372 is registered in ClinicalTrials.gov with University of Miami as lead sponsor.

NCT NCT00450372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00450372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Protocol for Phase II Testing of ADI-PEG 20 in Patients With Metastatic Melanoma
Lead sponsor
University of Miami
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2004
Completion date
February 29, 2012
Enrollment
38 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)